June 22, 2020 / 11:30 AM / 15 days ago

BRIEF-New Kidney360 Publication Highlights Caredx’S Allosure Is Differentiated As The Dd-Cfdna Test Of Choice

CareDx Inc:

* NEW KIDNEY360 PUBLICATION HIGHLIGHTS CAREDX’S ALLOSURE IS DIFFERENTIATED AS THE DD-CFDNA TEST OF CHOICE

* CAREDX INC - ALLOSURE WAS PROVEN TO BE MORE ACCURATE IN CLINICAL INTERPRETATION AND SIGNIFICANTLY FASTER IN DELIVERING PATIENT RESULTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below